H460 lung cancer cells are normally resistant to GPX4 inhibition due to high expression of a redundant anti-ferroptotic protein, ferroptosis suppressor protein 1 (FSP1)32 (Extended Data Fig. 2a). Here, GPX4 is linked to lung carcinoma.